Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

healthcare policy reform government

ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

Financial data showing growing revenue

Hospitals operating margins stand at 4.4%, the highest in over a year

The data comes from a report from Chicago-based consultancy firm Kaufman Hall, which releases a monthly analysis on the financial health of hospitals and health systems. Revenue growth is primarily driven by a rise of inpatient encounters. 

Medicaid money dollar reimbursement

Medicaid and SNAP cuts may eliminate over 1M jobs

According to a report published by the Commonwealth Fund, proposed federal budget cuts will devastate state economies, causing a ripple effect that leaves no industry unscathed. 

Video of Laxmi Mehta, MD, The Ohio State University Wexner Medical Center, explaining the causes of cardiologist burnout and possible solutions. She spoke on this topic at AHA 2024.

How to address cardiologist burnout

Laxmi Mehta, MD, detailed several ways she and her colleagues at The Ohio State University are working to combat the rising levels of burnout among cardiologists.

Edwards Lifesciences Corporation has shared new one-year data on the safety and effectiveness of its Evoque transcatheter tricuspid valve replacement (TTVR) system among patients with tricuspid regurgitation (TR)

CMS approves Medicare coverage for transcatheter tricuspid valve replacement

CMS will cover TTVR for the treatment of symptomatic tricuspid regurgitation on a national level. The agency first proposed such a policy in December, taking time to consider public comments before finalizing its decision.

Video of Dave Dixon explaining the impact of first FDA approval of a generic DOAC.

FDA clears first generic versions of rivaroxaban—what it means for patient care

Dave Dixon, PharmD, explored the short- and long-term impact of these approvals, noting that they could help reduce costs down the line.

Thumbnail

Americans' mental, physical health in steady decline since COVID-19 pandemic

The numbers are the lowest seen by Gallup in 25 years, with the percentage of adults reporting their health as “excellent” dropping in both categories. 

U.S. Department of Health and Human Services (HHS) HQ

HHS employees offered two months of pay to quit their jobs

That’s in addition to the $25,000 buyout offer from the federal government. Employees have until Friday to resign. 

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?